BCL2 and breast carcinoma: Intracellular staining of BCL-2 protein by flow cytometry revealed a significant reduction in BCL-2 levels in breast cancer cells likewise upon treatment with 200 μg/mL of siBCL-2 NKExos (Figure 5C).